Evidence map›Paper›PMID 42446965›Full record

ArticleJournal of medicinal chemistry2026

The Mycobacterial cyt-

Louisa Warryn, Matthias Witschel, Tobias Schehl, Daniela Prochazkova, Maryline Kienle, Francine Horn, Karl-Heinz Altmann, Daniel H Paris, Gerd Pluschke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Louisa WarrynSwiss Tropical and Public Health Institute, Allschwil 4123, Switzerland.ORCID 0000-0001-8660-1242
Matthias WitschelBASF SE, Ludwigshafen 67056, Germany.ORCID 0000-0003-0537-5146
Tobias SchehlBASF SE, Ludwigshafen 67056, Germany.
Daniela ProchazkovaBASF SE, Ludwigshafen 67056, Germany.
Maryline KienleDepartment of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Zürich CH-8093, Switzerland.
Francine HornDepartment of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Zürich CH-8093, Switzerland.ORCID 0000-0002-7296-3549
Karl-Heinz AltmannDepartment of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology Zürich, Zürich CH-8093, Switzerland.ORCID 0000-0002-0747-9734
Daniel H ParisSwiss Tropical and Public Health Institute, Allschwil 4123, Switzerland.
Gerd PluschkeSwiss Tropical and Public Health Institute, Allschwil 4123, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Control of

Indexed as

AmidesAnti-Bacterial AgentsMycobacterium ulceransPiperazinesQuinazolinesAdenosine TriphosphateMicrobial Sensitivity TestsStructure-Activity RelationshipAdenosine TriphosphateAmidesAnti-Bacterial AgentsPiperazinesQuinazolines

Identifiers

PMID42446965
PMCPMC13403322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.